|1.||Verma, Raj Kumar: 1 article (11/2015)|
|2.||Yu, Wei: 1 article (11/2015)|
|3.||Srivastava, Rakesh K: 1 article (11/2015)|
|4.||Shankar, Sharmila: 1 article (11/2015)|
|5.||Singh, Surya Pratap: 1 article (11/2015)|
|6.||Blagg, Brian S J: 1 article (01/2014)|
|7.||Davenport, Jason: 1 article (01/2014)|
|8.||Galam, Lakshmi: 1 article (01/2014)|
|9.||Balch, Maurie: 1 article (01/2014)|
|10.||Hall, Jessica: 1 article (01/2014)|
|1.||Pancreatic Neoplasms (Pancreatic Cancer)
11/01/2015 - "The objectives of this study were to examine the molecular mechanisms by which anthothecol-encapsulated PLGA-nanoparticles (Antho-NPs) regulate the behavior of pancreatic cancer stem cells (CSCs). "
11/01/2015 - "In this article, the authors investigated the efficacy and mechanism of anthothecol (an antimalarial compound), encapsulated by PLGA nanoparticles (Antho-NPs), against pancreatic cancer cell lines. "
11/01/2015 - "Anthothecol-encapsulated PLGA nanoparticles inhibit pancreatic cancer stem cell growth by modulating sonic hedgehog pathway."
|2.||Breast Neoplasms (Breast Cancer)
01/01/2014 - "Four compounds, anthothecol, garcinol, piplartine, and rottlerin, were further characterized, and the ability of these compounds to inhibit the refolding of luciferase, and reduce the rate of growth of MCF7 breast cancer cells, correlated with their ability to suppress the Hsp90-dependent maturation of the heme-regulated eIF2α kinase, and deplete cultured cells of Hsp90-dependent client proteins. "
|1.||polylactic acid-polyglycolic acid copolymer (PLGA)
|2.||Proteins (Proteins, Gene)